Titan Pharmaceuticals Announces Enrollment Reaches Halfway Mark in Phase 3 Study of Probuphine for Opioid Dependence September 23, 2014
Titan Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference September 3, 2014
Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2014 Financial Results August 7, 2014
Titan Pharmaceuticals Announces First Patient Enrollment in Clinical Study of Probuphine for Opioid Dependence July 21, 2014
Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2014 Financial Results May 8, 2014
Titan Pharmaceuticals Provides Overview of Upcoming Clinical Study of Probuphine Following Clear Guidance From the FDA April 30, 2014
